Publiko binalaan ng FDA sa mga hindi rehistradong produkto

By Justinne Punsalang August 08, 2017 - 08:11 PM

Inquirer file photo

Binabalaan ng FDA ang publiko sa pagbili ng ilang mga produktong na hindi rehistrado sa naturang ahensya.

Ayon sa FDA Advisory No. 2017-226, ipinagbabawal ng ahensya na bilhin ang:

Dan Cel Purified Drinking Water

Chinese Garlic Pearles

Carica Lagundi Capsule

NuWhite Advanced Whitening

L-Glutathione Collagen & Placenta Food Supplement Encore Premium Chili Powder Dream and Love Pumpkin Candy Beksul Wheat Flour

Premium Quality Flour

Dong Won Tuna with Korean BBQ Sauce

Crown Choco

Heim Choco Hazelnut

Ottogi Vegetable Cream Soup

Ottogi Mushroom Cream Soup

Ottogi Beef Cream Soup

Sa ilalim naman ng FDA Advisory No. 2017-227, ipinagbabawal ng FDA ang pagbili sa mga sumusunod na food products at food supplements:

Beskul Flavored Salt

Nature Made B12 Vitamin 1000

Dietary Supplement

AGV Panacea Ion Care Eye Drops

Health Source Melatonin Softgel

Green Bee Green Tea Food Supplement (Camelia Sinesis)

Green Bee Guyabano Tea (Anona muricata)

Food Supplement ELYACON Herbal Tea 100 %

Organic Food Supplement Lemon, 200ml

Sauce in Japanese Characters 250 ml Maruha Nichiro Oyako Don Calpis Water

Ayon sa ahensya, matapos ang kanilang isinagawang post-marketing surveillance, napagalaman na ang mga naturang produkto ay hindi dumaan sa registration process at hindi binigyan ng kaukulang authorization o Certificate of Product Registration.

Ipinagbabawal sa ilalim ng RA 9711 o Food and Drug Administration Act of 2009 ang paggawa, pagbenta, pag-import at export ng mga produktong hindi rehistrado sa FDA.

TAGS: beauty products, FDA, warning, beauty products, FDA, warning

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.